loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Tablet Delayed Release Finished Formulations containing Methacrylic Acid Methyl Methacrylate Copolymer Excipient? Find Methacrylic Acid Methyl Methacrylate Copolymer 1:2 based pharmaceutical excipients on PharmaCompass.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Methacrylic Acid Methyl Methacrylate Copolymer 1:2

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1AEMCOLO

    02 1ASACOL

    03 1ASACOL HD

    04 1LIALDA

    05 2MESALAMINE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    Luxepack
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : ASACOL HD

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 21830

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    APIL

    MESALAMINE

    arrow
    Luxepack
    Not Confirmed
    APIL
    Country
    arrow
    Luxepack
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : ASACOL

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 19651

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    REDHILL

    RIFAMYCIN SODIUM

    arrow
    Luxepack
    Not Confirmed
    REDHILL
    Israel
    arrow
    Luxepack
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RIFAMYCIN SODIUM

    Drug : AEMCOLO

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 210910

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    SUN PHARM

    MESALAMINE

    arrow
    Luxepack
    Not Confirmed
    SUN PHARM
    India
    arrow
    Luxepack
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : MESALAMINE

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 211858

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    TAKEDA PHARMS USA

    MESALAMINE

    arrow
    Luxepack
    Not Confirmed
    TAKEDA PHARMS USA
    Japan
    arrow
    Luxepack
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : LIALDA

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 22000

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    MYLAN

    MESALAMINE

    arrow
    Luxepack
    Not Confirmed
    MYLAN
    U.S.A
    arrow
    Luxepack
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : MESALAMINE

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 203574

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF